LEY; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEY; Klaus.The latest application filed is for "human apob100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis".

Company Profile

5.1.10

LEY; Klaus - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Apob100 Epitopes, Methods And Uses For Modulating Inflammatory Responses, And Treating Adverse Cardiovascular Events, Disease And Atherosclerosis App 20220259288 - LEY; Klaus ; et al.	2022-08-18
Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis Grant 11,130,798 - Ley , et al. September 28, 2	2021-09-28
Modulating Immune Response Via Targeting Of Olfactory Receptor Activity App 20210145768 - LEY; Klaus ; et al.	2021-05-20
Methods And Devices For Gaseous Sample Collection And Storage App 20200060662 - Kassab; Ghassan S. ; et al.	2020-02-27
Human Apob100 Epitopes, Methods And Uses For Modulating Inflammatory Responses, And Treating Adverse Cardiovascular Events, Disease And Atherosclerosis App 20200031905 - LEY; Klaus ; et al.	2020-01-30
Methods And Compositions Using Integrin-based Therapeutics App 20180369330 - Ley; Klaus	2018-12-27
Methods Of Inhibiting Adverse Cardiac Events And Treating Atherosclerosis And Coronary Artery Disease Using Galectin-3 Binding Protein (gal-3bp, Btbd17b, Mac-2 Binding Protein) App 20150119333 - LEY; Klaus ; et al.	2015-04-30
Methods And Uses Of Nur77 And Nur77 Agonists To Modulate Macrophages And Monocytes, And Treat Inflammation, Inflammatory Disease And Cardiovascular Disease App 20130108602 - Hedrick; Catherine C. ; et al.	2013-05-02
METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN) App 20130095127 - Ley; Klaus ; et al.	2013-04-18
Methods Of Inhibiting Adverse Cardiac Events And Treating Atherosclerosis And Coronary Artery Disease Using Galectin-3 Binding Protein (gal-3bp, Btbd17b, Mac-2 Binding Protein) App 20120121590 - Ley; Klaus ; et al.	2012-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.